Crespi M, Dulbecco P, De Ceglie A, Conio M, Springer. Strictures in Crohn’s disease: from pathophysiology to treatment. Dig Dis Sci. 2020;65:1904–16. https://doi.org/10.1007/s10620-020-06227-0.

Article  PubMed  Google Scholar 

Alfredsson J, Wick MJ, Blackwell Publishing Ltd. Mechanism of fibrosis and stricture formation in Crohn’s disease. Scand J Immunol. 2020. https://doi.org/10.1111/sji.12990.

Rimola J, Capozzi N, Korean Association for the Study of Intestinal Diseases. Differentiation of fibrotic and inflammatory component of Crohn’s disease-associated strictures. Intest Res. 2020;18:144–50. https://doi.org/10.5217/ir.2020.00015.

Article  PubMed  PubMed Central  Google Scholar 

Désogère P, Montesi SB, Caravan P, Wiley-VCH Verlag. Molecular probes for imaging fibrosis and fibrogenesis. Chem Eur J. 2019;25:1128–41. https://doi.org/10.1002/chem.201801578.

Article  PubMed  CAS  Google Scholar 

Désogère P, Tapias LF, Hariri LP, Rotile NJ, Rietz TA, Probst CK et al. Type I collagen–targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci Transl Med [Internet]. American Association for the Advancement of Science; 2017;9. https://doi.org/10.1126/scitranslmed.aaf4696

Solitano V, Dal Buono A, Gabbiadini R, Wozny M, Repici A, Spinelli A, et al. Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? J Clin Med. 2023;12:3052. https://doi.org/10.3390/jcm12093052.

Allocca M, Fiorino G, Bonifacio C, Peyrin-Biroulet L, Danese S, W.B. Saunders. Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn’s Disease. Clin Gastroenterol Hepatol. 2019;17:2397–415. https://doi.org/10.1016/j.cgh.2019.04.025.

Article  PubMed  Google Scholar 

Sleiman J, Chirra P, Gandhi NS, Baker ME, Lu C, Gordon IO, et al. Crohn’s disease related strictures in cross-sectional imaging: more than meets the eye? United Eur Gastroenterol J. 2022;10:1167–78. https://doi.org/10.1002/ueg2.12326.

Lin X, Wang Y, Liu Z, Lin S, Tan J, He J, et al. Intestinal strictures in Crohn’s disease: a 2021 update. Therap Adv Gastroenterol. 2022. https://doi.org/10.1177/17562848221104951.

Montesi SB, Izquierdo-Garcia D, Désogère P, Abston E, Liang LL, Digumarthy S, et al. Type I collagen–targeted positron emission tomography imaging in idiopathic pulmonary fibrosis: first-in-human studies. Am J Respir Crit Care Med. 2019;200:258–61. https://doi.org/10.1164/rccm.201903-0503LE.

Montesi SB, Désogère P, Fuchs BC, Caravan P, American Society for Clinical Investigation. Molecular imaging of fibrosis: recent advances and future directions. J Clin Invest. 2019;129:24–33. https://doi.org/10.1172/JCI122132.

Article  PubMed  PubMed Central  Google Scholar 

Izquierdo-Garcia D, Désogère P, Fur M Le, Shuvaev S, Zhou IY, Ramsay I, et al. Biodistribution, dosimetry, and pharmacokinetics of 68Ga-CBP8: a type I collagen-targeted PET probe. J Nucl Med. 2023;64:775–81. https://doi.org/10.2967/jnumed.122.264530.

Moon BF, Zhou IY, Ning Y, Chen YI, Le Fur M, Shuvaev S, et al. Simultaneous Positron Emission Tomography and Molecular Magnetic Resonance Imaging of Cardiopulmonary Fibrosis in a Mouse Model of Left Ventricular Dysfunction. American Heart Association Inc.; 2024. p. 13. https://doi.org/10.1161/JAHA.124.034363. J Am Heart Assoc [Internet].

Xiong S, Whitehurst CE, Li L, Heo GS, Lai C-W, Jain U, et al. Reverse translation approach generates a signature of penetrating fibrosis in crohn’s disease that is associated with anti-TNF response. Gut [Internet] BMJ Publishing Group. 2022;71:1289–301. https://doi.org/10.1136/gutjnl-2020-323405.

Article  CAS  Google Scholar 

The jamovi project. (2024). jamovi. (Version 2.6) [Computer Software]. Retrieved from https://www.jamovi.org

R Core Team. (2024). R: A Language and environment for statistical computing. (Version 4.4) [Computer software]. Retrieved from https://cran.r-project.org. (R packages retrieved from CRAN snapshot 2024-08-07).

Liu Y, Tang P, Peng S, Zhong J, Xu Z, Zhong J, et al. [18F]AlF-CBP imaging of type I collagen for non-invasive monitoring of pulmonary fibrosis in preclinical models. Eur J Nucl Med Mol Imaging. 2024;52:22–35. https://doi.org/10.1007/s00259-024-06888-3.

Montesi SB, Cosgrove GP, Turner SM, Zhou IY, Efthimiou N, Susnjar A, et al. Dual αvβ6 and αvβ1 inhibition over 12 weeks reduces active type 1 collagen deposition in individuals with idiopathic pulmonary fibrosis: a phase 2, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med. 2025. https://doi.org/10.1164/rccm.202410-1934OC.

Article  PubMed  PubMed Central  Google Scholar 

Abston E, Zhou IY, Saenger JA, Shuvaev S, Akam E, Esfahani SA, et al. Noninvasive quantification of radiation-induced lung injury using a targeted molecular imaging probe. Int J Radiat Oncol Biol Phys. 2024;118:1228–39. https://doi.org/10.1016/j.ijrobp.2023.11.032.

Esfahani SA, Ma H, Krishna S, Shuvaev S, Sabbagh M, Deffler C, et al. Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies. Theranostics. 2024;14:5745–61. https://doi.org/10.7150/thno.100116.